Efficacy of adjunctive treatment with trimetazidine for fragmented QRS among patients with ischemic heart failure: a propensity score match analysis

Selçuk KANAT; Barış ŞENSOY

doi:https://doi.org/10.18621/eurj.397369

Makale detayları

Efficacy of adjunctive treatment with trimetazidine for fragmented QRS among patients with ischemic heart failure: a propensity score match analysis

Yazarlar:

Selçuk KANAT | Barış ŞENSOY

Yayıncı:

Prusa Medical Publishing

Ana Başlıklar:

Sağlık teşvikleri

Dergi:

The European Research Journal 2019 Vol.5 Issue 2, pp.291-298

Belge Tipi:

Makale

Yayın Tarihi:

3/2019

Belge Dili:

İngilizce

Document ID (Org No.):

2000662827

Sıklık:

İki Aylık

eISSN:

2149-3189

DOI:

https://doi.org/10.18621/eurj.397369

Özet:

 


Objectives: Fragmented QRS (fQRS) is an indicator of nonhomogeneous ventricular
activity caused by myocardial ischemia and fibrosis. The anti-ischemic agent
trimetazidine (TMZ) added to pharmacological treatment appears to have positive
effects on cardiac parameters of patients with ischemic heart failure. We aimed
to investigate the relationship of fQRS with adjunctive TMZ therapy in ischemic
HF patients. 


Methods: Four hundred eighty-nine consecutive ambulatory ischemic patients with heart
failure eligible for our study were recruited for the study. A 12-lead
electrocardiogram with standard chest and limb leads was used to evaluate the
presence of fQRS. Further patients were divided into groups according to
adjunctive TMZ treatment and fQRS presence. Confounding factors were adjusted
by propensity score matching and multivariate logistic regression analysis. 


Results: One hundred ninety-seven (40.3%) patients had fQRS on their ECGs and 235
(48.1%) patients were on adjunctive treatment with trimetazidine. Compared to
patients without fQRS, patients with fQRS had lower left ventricular ejection
fraction (LVEF), higher NYHA classes and more frequent mineralocorticoid
receptor antagonist and diuretic usage (p < 0.05). Add-on treatment
with TMZ was independently associated with fQRS presence (OR, 0.45; (95% CI,
0.29-0.70); p < 0.0001). 









Conclusion: According to conventional therapy, adjunctive treatment with TMZ among
ischemic heart failure patients can be associated with fQRS in 12-lead ECG
independent of LVEF.





.

Makale detayları

Efficacy of adjunctive treatment with trimetazidine for fragmented QRS among patients with ischemic heart failure: a propensity score match analysis

Yazarlar: Selçuk KANAT | Barış ŞENSOY

Yayıncı: Prusa Medical Publishing

Ana Başlıklar: Sağlık teşvikleri

Dergi: The European Research Journal 2019 Vol.5 Issue 2, pp.291-298

Belge Tipi: Makale

Yayın Tarihi: 3/2019

Belge Dili: İngilizce

Document ID (Org No.): 2000662827

Sıklık: İki Aylık

eISSN: 2149-3189

DOI: https://doi.org/10.18621/eurj.397369

Sayı

Yazarlar:

Selçuk KANAT | Barış ŞENSOY

Yayıncı:

Prusa Medical Publishing

Ana Başlıklar:

Sağlık teşvikleri

Dergi:

The European Research Journal 2019 Vol.5 Issue 2, pp.291-298

Belge Tipi:

Makale

Yayın Tarihi:

3/2019

Belge Dili:

İngilizce

Document ID (Org No.):

2000662827

Sıklık:

İki Aylık

eISSN:

2149-3189

DOI:

https://doi.org/10.18621/eurj.397369